Naprosyn

Developed to mitigate musculoskeletal inflammation to relieve discomfort.

Strengths: 250 · 500mg

Medicine details

Alternative names

Anaprox; Ecxen; Stirlescent

Therapeutic class

NSAID

Pharmacological class

Propionic Acid Derivative

Precautions and warnings

avoid in patients with bleeding disorders; monitor cardiovascular health

Minor side effects

nausea; headache

Moderate side effects

abdominal pain; constipation

Dosage forms

Tablet; Gastro-resistant tablet

Administration route

Oral use

Patient summary

Developed to mitigate musculoskeletal inflammation to relieve discomfort.

Prescription status

POM

Manufacturer

Roche

Onset Time

30–60 minutes

Duration

8–12 hours

Storage instructions

Store below 25°C.

Drug interactions

antihypertensives; diuretics; SSRIs

Age restrictions

Not for children unless on specialist advice.

Contraindications

peptic ulceration; severe impairment of renal function; hypersensitivity to NSAIDs

Serious side effects

gastrointestinal perforation — requires immediate medical attention; anaphylactoid reaction — requires immediate medical attention

Mechanism of action

Naprosyn works by inhibiting the synthesis of prostaglandins, which are key mediators in the inflammatory response, providing analgesic and anti-inflammatory effects.

Pregnancy and breastfeeding

Pregnancy: Avoid in third trimester. Breastfeeding: Use with caution; consult physician.

Naprosyn

Developed to mitigate musculoskeletal inflammation to relieve discomfort.

Editorial Notes

  • Active ingredient(s): Naproxen
  • Listed indication(s): Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis

Usually available as

  • 180 tablets - 250 mg166-250-mg-3667
  • 90 tablets - 500 mg166-500-mg-3671